Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

Background & Aims: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We a...

Full description

Bibliographic Details
Main Authors: Elton Dajti, Giovanni Marasco, Federico Ravaioli, Luigi Colecchia, Alberto Ferrarese, Davide Festi, Antonio Colecchia
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:JHEP Reports
Subjects:
Spleen stiffness
Liver stiffness
Transient elastography
HCC
DAA
Direct-acting antiviral
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555921000653

Internet

http://www.sciencedirect.com/science/article/pii/S2589555921000653

Similar Items